Celadon Pharmaceuticals (CEL) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 Feb 2022 11:00 AM
RNS
Price Monitoring Extension
28 Feb 2022 09:05 AM
RNS
Second Price Monitoring Extn
28 Feb 2022 09:00 AM
RNS
Price Monitoring Extension
28 Feb 2022 07:00 AM
RNS
Proposed Acquisition, Fundraise & Restoration
30 Nov 2021 07:00 AM
RNS
Unaudited Interim Report
29 Nov 2021 03:17 PM
RNS
Change in Accounting Reference Date
28 Oct 2021 09:15 AM
RNS
Proposed Acquisition
20 Oct 2021 03:35 PM
RNS
Result of General Meeting
24 Sep 2021 05:06 PM
RNS
Posting of Circular and Notice of General Meeting
21 Sep 2021 01:30 PM
RNS
Company Update
11 May 2021 07:00 AM
RNS
Interim Report
09 Apr 2021 11:32 AM
RNS
Holding(s) in Company
09 Apr 2021 11:30 AM
RNS
Director/PDMR Shareholding
26 Feb 2021 10:57 AM
RNS
Result of Annual General Meeting
02 Feb 2021 07:00 AM
RNS
Final results
15 Jan 2021 10:47 AM
RNS
Result of GM, TVR, Directorate Changes and RPT
14 Jan 2021 04:41 PM
RNS
Second Price Monitoring Extn
14 Jan 2021 04:36 PM
RNS
Price Monitoring Extension
04 Jan 2021 02:05 PM
RNS
Second Price Monitoring Extn
04 Jan 2021 02:00 PM
RNS
Price Monitoring Extension
23 Dec 2020 09:58 AM
RNS
Posting of Circular, Notice of GM and RPT
18 Dec 2020 02:05 PM
RNS
Second Price Monitoring Extn
18 Dec 2020 02:00 PM
RNS
Price Monitoring Extension
16 Dec 2020 09:05 AM
RNS
Second Price Monitoring Extn
16 Dec 2020 09:00 AM
RNS
Price Monitoring Extension
15 Dec 2020 01:10 PM
RNS
Investing Policy, Board Changes and Placing
19 May 2020 07:00 AM
RNS
Interim Report
27 Feb 2020 03:00 PM
RNS
Result of AGM
29 Jan 2020 07:00 AM
RNS
Final Results
29 May 2019 07:00 AM
RNS
Interim Report
19 Oct 2018 07:00 AM
RNS
Admission and First Day of Dealings
08 Aug 2008 05:12 PM
RNS
Holding(s) in Company
19 Mar 2003 07:30 AM
RNS
Pre Close Trading Update

Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on researching, cultivating, manufacturing, and supplying breakthrough cannabis-based medicines, primarily for chronic pain. The company operates a large, licensed facility in the West Midlands with indoor hydroponic cultivation and an EU-GMP standard laboratory.

Celadon Pharmaceuticals' share price was cancelled on 8 August 2025.

UK 100